Seattle, WA, United States of America

Elizabeth Broussard

This inventor holds 1 USPTO granted patent. Top assignee: University of Washington. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Broussard. Retrieved from https://idiyas.com/inventor/elizabeth-broussard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elizabeth Broussard: Innovator in Cancer Vaccine Research

Introduction

Elizabeth Broussard is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of cancer research, particularly in the development of vaccine compositions. Her work aims to enhance immune responses in subjects, providing hope for improved cancer treatments.

Latest Patents

Elizabeth Broussard holds a patent for "Cancer vaccine compositions and methods of use thereof." This patent describes compositions that include an epitope of a peptide that elicits an immune response in a subject following administration. The compositions also include nucleic acids and peptides, with methods for administering these compositions to subjects in need.

Career Highlights

Broussard is affiliated with the University of Washington, where she conducts her research and development work. Her innovative approach to cancer vaccines has positioned her as a key figure in the scientific community.

Collaborations

One of her notable collaborators is Mary L Disis, who shares a commitment to advancing cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in the field.

Conclusion

Elizabeth Broussard's work in cancer vaccine research represents a significant advancement in medical science. Her contributions are paving the way for new therapeutic options for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…